GlaxoSmithKline Newswire

GlaxoSmithKline Newswire

Comprehensive Real-Time News Feed for GlaxoSmithKline.

Results 1 - 20 of 1,861 in GlaxoSmithKline

  1. Healthcare Dividend Dogs: 3% To 10% Yields From Top 10 As Of July 29Read the original story w/Photo

    21 hrs ago | Seeking Alpha

    ... PDLI ) [1] and Theravance Inc. (NASDAQ: THRX ) [2]. The best of five drug manufacturers placed third, GlaxoSmithKline PLC (NYSE: GSK ) [3]. The other drug manufacturers arranged themselves in sixth, and eighth to tenth places: AstraZeneca (NYSE: AZN ...

    Comment?

  2. Decision paves way for WHO to assess malaria vaccineRead the original story w/Photo

    Yesterday | GhanaWeb

    PATH's Malaria Vaccine Initiative says it welcomes the positive scientific opinion adopted by European regulatory authorities for GlaxoSmithKline candidate malaria vaccine Mosquirixa for prevention of malaria in young children aged 6 weeks to 17 months in sub-Saharan Africa. A statement copied to GNA said, PATH was joined in its response by leading African researchers from sites that conducted the pivotal Phase three efficacy and safety trial.

    Comment?

  3. Ring vaccination method puts strangle hold on spread of EbolaRead the original story w/Photo

    Yesterday | Examiner.com

    ... Nigeria, Liberia and Sierra Leone, etc. It was also noted that additional trials for other vaccines made by GlaxoSmithKline and Johnson & Johnson are also being conducted, although judging their effectiveness has been difficult to access due to the ...

    Comment?

  4. HealthWorld's first malaria vaccine approved by EMAThe world's first...Read the original story w/Photo

    Friday | RedOrbit

    The world's first malaria vaccine has gotten a thumbs up from the European Medicine Agency for use outside the European Union, paving the way for a WHO policy recommendation by November. The vaccine, known as Mosquirix or RTS,S, has been developed over the course of 30 years by GlaxoSmithKline with funding from the Bill and Melinda Gates Foundation.

    Comment?

  5. Parexel to lay off 125 in North Carolina who were recently laid off by GSKRead the original story w/Photo

    Friday | Business Journal

    A group of former GlaxoSmithKline employees will receive their second pink slip in less than a year when pharmaceutical research organization Parexel International Corporation lays off 125 workers in North Carolina's Research Triangle Park.

    Comment?

  6. On the Move: Changes at Google, H+K, DAC, Dynamic OutdoorRead the original story w/Photo

    Friday | Marketing

    ... Weber Shandwick, and has also held lead communications roles at the Canadian Partnership Against Cancer and GlaxoSmithKline. H+K also minted two new VPs from within its ranks: COLIN SMILIE, VP of digital communications and engagement strategies in ...

    Comment?

  7. GSK hiring and Parexel making cuts - but the job functions don't matchRead the original story w/Photo

    Friday | Business Journal

    On Thursday, pharmaceutical research company Parexel International Corporation disclosed it would lay off 125 workers from a business unit that transferred from drug maker GlaxoSmithKline . On the same day, GSK said it would hire 130 workers, raising the obvious question: Can't the laid-off Parexel workers just come to GSK? As giant companies, both Parexel and GSK have many different job functions and put simply, the type of workers GSK wants to hire in Zebulon are different from the types of workers laid off in Research Triangle Park.

    Comment?

  8. Ebola vaccine works, offering 100% protection in African trialRead the original story w/Photo

    Friday | Science

    ... is one of two vaccines currently being tested in the Ebola-stricken countries; the other one is produced by GlaxoSmithKline (GSK). The study was led by Ana Maria Henao-Restrepo of the World Health Organization (WHO) in Geneva, together with ...

    Comment?

  9. Parexel to lay off up to 125 transferred GSK employeesRead the original story w/Photo

    Friday | Drug Researcher

    Beginning Sept. 30, Massachusetts-based CRO Parexel will lay off as many as 125 of the 450 employees it brought on from GlaxoSmithKline in North Carolina late last year, according to a North Carolina WARN report obtained by Outsourcing-Pharma.com.

    Comment?

  10. Wow, Americans Really Aren't Fans Of The Life-Saving HPV VaccineRead the original story w/Photo

    Friday | The Huffington Post

    The percentage of U.S. teenagers vaccinated against the human papillomavirus increased slightly in 2014, but the rate lags behind other immunizations, the Centers for Disease Control and Prevention said on Thursday. The HPV vaccine, sold as Gardasil by Merck & Co and Cervarix by GlaxoSmithKline, protects against the most common sexually transmitted infection.

    Comment?

  11. Theravance: On Track To Deliver Rising DividendsRead the original story w/Photo

    Friday | Seeking Alpha

    Based on GSK's published H1/2015 results I feel confident that my Q4/14 royalty forecast will prove to have been pretty accurate. In fact, it has recently named a new CBO to work on initiatives beyond the company's existing respiratory portfolio.

    Comment?

  12. Consumer Reports: Fakes, phonies and frauds flow hereRead the original story w/Photo

    Thursday | Post-gazette.com

    ... supplier and may have been sold to doctors' offices and clinics nationwide. Alli. Lab tests conducted by GlaxoSmithKline, the U.K.-based maker of the real over-the-counter weight-loss product, revealed that a fake, which was sold online, lacked ...

    Comment?

  13. HPV vaccinations for U.S. teens rise slightly: CDCRead the original story

    Thursday | Reuters

    The percentage of U.S. teenagers vaccinated against the human papillomavirus increased slightly in 2014, but the rate lags behind other immunizations, the Centers for Disease Control and Prevention said on Thursday. The HPV vaccine, sold as Gardasil by Merck & Co and Cervarix by GlaxoSmithKline, protects against the most common sexually transmitted infection.

    Comment?

  14. Parexel to lay off 125 workers in the TriangleRead the original story w/Photo

    Thursday Jul 30 | Business Journal

    A group of former GlaxoSmithKline employees will receive their second pink slip in less than a year when pharmaceutical research organization Parexel International Corporation lays off 125 workers in the Triangle. A Parexel spokeswoman confirmed this latest round of layoffs will affect the Research Triangle Park Sanders Building location, the planned home for those GSK workers .

    Comment?

  15. HPV vaccinations for U.S. teens rise slightly -CDCRead the original story

    Thursday Jul 30 | Reuters

    The percentage of U.S. teenagers vaccinated against the human papillomavirus increased slightly in 2014, but the rate lags behind other immunizations, the Centers for Disease Control and Prevention said on Thursday. The HPV vaccine, sold as Gardasil by Merck & Co and Cervarix by GlaxoSmithKline, protects against the most common sexually transmitted infection.

    Comment?

  16. GSK to hire 130 workers in Zebulon to make next-gen asthma drugsRead the original story w/Photo

    Thursday Jul 30 | Business Journal

    As drug giant GlaxoSmithKline prepares to make its next-generation asthma drugs in Zebulon, the company plans to hire 100 workers this year and another 30 to 40 next year. When it completes that many hires, it would bring the company close to 1,000 employees in the manufacturing facility responsible for making the asthma drug Advair, a major driver of GSK revenue.

    Comment?

  17. GlaxoSmithKline Sees Staged Roll-Out Of Malaria VaccineRead the original story w/Photo

    Thursday Jul 30 | Medical Daily

    The world's first malaria vaccine, which won a green light last week from European drugs regulators, will be rolled out gradually in Africa, its maker said on Wednesday. "We believe that there should be a thoughtful, staged roll-out of this vaccine, particularly because it is important that we acquire more knowledge about where it really works the best," GlaxoSmithKline Chief Executive Andrew Witty told reporters.

    Comment?

  18. Financial Report: GlaxoSmithKlineRead the original story w/Photo

    Thursday Jul 30 | Contract Pharma Breaking News

    GlaxoSmithKline 2Q Revenues: 5.9 billion 2Q Earnings: 115 million YTD Revenues: 11.5 billion YTD Earnings: 8.2 billion Comments: Pharmaceutical sales were 3.5 billion, down 6% primarily reflecting the sale of the oncology business to Novartis. Respiratory sales declined 6%, reflecting further declines in Seretide/Advair in both the U.S. and Europe and the continuing transition of the portfolio to newer products.

    Comment?

  19. Mixed fortunes for Europe's pharmasRead the original story w/Photo

    Thursday Jul 30 | Reuters

    AstraZeneca beats profit forecasts and raises its revenue outlook, but reports emerge of new corruption allegations against GlaxoSmithKline. David Pollard reports.

    Comment?

  20. Exclusive: GSK Faces New Corruption Allegations, This Time In RomaniaRead the original story w/Photo

    Thursday Jul 30 | Medical Daily

    Drugmaker GlaxoSmithKline, which was fined a record 3 billion yuan for corruption in China last year and is examining possible staff misconduct elsewhere, faces new allegations of bribery in Romania. GSK confirmed it was looking into the latest claims of improper payments set out in a whistleblower's email sent to its top management on Monday.

    Comment?